Skip to content
healthcare.dev

Oxytrol for Women

NDC 0023-9637, Oxybutynin, patch, from Allergan, Inc..

Product NDC
0023-9637
Status
Listed
Labeler
Allergan, Inc.
Dosage form
PATCH
Route
TRANSDERMAL
Product type
HUMAN OTC DRUG
Marketing category
NDA
Application
NDA202211
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0023-9637 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OXYBUTYNIN3.9 mg/d

Pharmacologic classes

Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]

Package NDCNDC-11Package
0023-9637-040002396370416 PATCH in 1 CARTON (0023-9637-04) / 4 d in 1 PATCH
0023-9637-080002396370832 PATCH in 1 CARTON (0023-9637-08) / 4 d in 1 PATCH

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • NADAC price for package 00023963704

    GET /v1/drugs/nadac/00023963704
  • NADAC price for package 00023963708

    GET /v1/drugs/nadac/00023963708

Use it

Look up 0023-9637 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0023-9637 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0023-9637. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.